Schizophrenia Clinical Trial
Official title:
EXPLORATION OF THE SOCIAL COGNITION IN ADOLESCENTS WITH A Dissociative Disorder OR AUTISM SPECTRUM
The schizophrenic disorders and pervasive developmental disorders are neurodevelopmental
disorders distinct origin who share common challenges to engage and maintain social
relationships and mutual disturbances of affective contact. An important issue of research
is to determine the cognitive and brain mechanisms underlying social disability in these two
pathologies. Several lines of social cognition have been systematically explored: the
perception of emotions, the ability to attribute intentionality and mental states to others
(theory of mind), the understanding of social situations in different contexts. We made the
observation today that research findings clearly in the field of autism and schizophrenic
disorders that converge on common patterns neurocognitive abnormalities. Consequently, many
programs support published today use the same therapeutic targets and the same tools in both
pathologies. This raises two questions of science: (1) whether the disorders of social
cognition reported in the field of autism and schizophrenia are "specific deficit" and not
"specific condition", that is to say they are inherent social disadvantage whatever
condition or (2) if these disorders of social cognition is a pattern common to autism and
schizophrenia but are the result of specific neurocognitive mechanisms and different in each
these pathologies. Systematic exploration of these issues is a current issue for
understanding the pathophysiological borders between the two neurodevelopmental disorders
but also to better define the potential targets of therapeutic strategies,
psycho-educational and remediation of disorders of social cognition in autism and
schizophrenia.
Main objective: To compare clinical cognitive profiles in adolescents with a schizophrenic
disorder, autistic or healthy in the three areas of social cognition: perception of
emotions, attribution of intentions to others (theory of mind) and style attribution. We
shall constitute three population groups of patients, a group of patients meeting the
diagnosis of schizophrenia, a group of patients with autism and a control group (healthy
subjects).
Status | Completed |
Enrollment | 60 |
Est. completion date | May 2013 |
Est. primary completion date | April 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 12 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Child with a DSM-IV diagnosis of schizophrenia or autism spectrum disorder: - Schizophrenic patients, positive to the award of psychosis section of the Kiddie SADS and having a negative ADI. or: - Patients with autism spectrum disorder, diagnosed by the scale ADI (Autism Diagnostic Interview) or ADOS (Autism Diagnostic Observation Schedule): Autism Asperger and PDD nos. These patients do not respond to a diagnosis of psychosis Kiddie-SADS according. - Total IQ greater than or equal to 70 Exclusion Criteria: - Genetic disorders, neurological and neurosensory - Child satisfy both the diagnosis of autism spectrum disorder and schizophrenia than (comorbidity). - Will not be included patients who participate in a study on rehabilitation for social skills. |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier d'Antibes Juans les Pins | Antibes | |
France | Centre hospitalier de Cannes | Cannes | |
France | CHU de Nice | Nice |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nice | Centre Hospitalier d'Antibes Juans les Pins, Centre Hospitalier de Cannes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare cognitive profiles in clinical adolescents with a schizophrenic disorder, autistic or healthy in the three areas of social cognition | Compare cognitive profiles in clinical adolescents with a schizophrenic disorder, autistic or healthy in the three areas of social cognition: the perception of emotions, attribution of intentions to others (theory of mind) and style attribution. We will study the brain evoked potentials during the execution of the task of facial emotion recognition. |
First day | No |
Secondary | Compare the cognitive profiles within the clinical group of schizophrenic | Compare the cognitive profiles within the clinical group of schizophrenic patients, depending on the type of schizophrenia presented (as positive, negative or disorganized). For the study of attribution of intentions to others: This is to test the understanding of metaphors patients. Three types of statements are presented: forward literals, metaphorical statements and statements incongruous; patients should judge the plausibility semantics of these sentences. We study the behavioral and electrophysiological data. |
First day | No |
Secondary | Cognitive profiles compare clinical results between the different types of schizophrenia and autism patients. | Cognitive profiles compare clinical results between the different types of schizophrenia and autism patients. Self-assessment in the form of a questionnaire with several social situations of everyday life. The subject must plan and assign intentionality to a character. We get scores dimensions studied. |
First day | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |